Roche’s Alzheimer antibody granted U.S. FDA Breakthrough Therapy Designation
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
Alnylam is the latest partner in the Medicines Manufacturing Innovation Centre’s third Grand Challenge project, which aims to revolutionise the manufacturing process for oligonucleotide therapies
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
Bharat Biotech has been submitting data to the WHO on a rolling basis and submitted additional information at WHO’s request on September 27th 2021
This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
The site's strategic location in the logistics hubs of the Auvergne Rhone-Alpes region is an advantage, along with the benefit of geographical proximity to Arrow's headquarters in Lyon
Fortis Memorial Research Institute is the only hospital in India and South Asia to acquire the machine
These pouches, manufactured at UFlex India plant, will be exported to American markets and will be majorly used for packing edible products
A team of experts at Fortis Gurugram conducted 3-dimensional mapping with the help of the new system Carto version 7 to precisely map the source of the arrhythmia. It was detected that the arrhythmia was coming from the conduction system i.e. body’s natural wiring.
Subscribe To Our Newsletter & Stay Updated